デフォルト表紙
市場調査レポート
商品コード
1148027

超崩壊剤の世界市場(2022年~2028年):COVID-19の影響分析、タイプ別、製剤別、治療領域別、地域別 - 業界分析、市場規模、市場シェア、予測

Superdisintegrants Market with COVID-19 Impact Analysis, By Type, By Formulation, By Therapeutic Area and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 247 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.56円
超崩壊剤の世界市場(2022年~2028年):COVID-19の影響分析、タイプ別、製剤別、治療領域別、地域別 - 業界分析、市場規模、市場シェア、予測
出版日: 2022年09月01日
発行: AnalystView Market Insights
ページ情報: 英文 247 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の超崩壊剤の市場規模は、2021年に4億9,070万米ドルとなり、2022年~2028年の予測期間中に7.2%のCAGRで拡大すると予想されています。

当レポートでは世界の超崩壊剤市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 超崩壊剤市場:概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • タイプ別
    • 製剤別
    • 治療領域別
    • 地域別
  • 競合洞察

第3章 超崩壊剤市場:主要な動向

  • 市場促進要因
    • 市場促進要因の影響分析
  • 市場抑制要因
    • 市場抑制要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 超崩壊剤:業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制の枠組みの分析

第5章 超崩壊剤市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 超崩壊剤市場:情勢

  • 市場シェア分析(2021年)
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 超崩壊剤市場:タイプ別

  • 概要

第8章 超崩壊剤市場:製剤別

  • 概要

第9章 超崩壊剤市場:治療領域別

  • 概要

第10章 超崩壊剤市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 ベンダー分析

  • 競合ダッシュボード
  • 企業プロファイル
    • BASF SE
    • DuPont
    • Ashland Global Holdings Inc.
    • Roquette Freres
    • DFE Pharma
    • JRS PHARMA
    • Asahi Kasei Corporation
    • Merck KGaA
    • Corel Pharma Chem
    • Avantor Performance Materials
    • NIPPO SODA CO., LTD.
    • Sigachi Industries
    • Colorcon
    • NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.

第12章 アナリストの包括的展望

第13章 付録

図表

List of Tables

  • TABLE List of data Types
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Superdisintegrants Market: Type Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Superdisintegrants Market, by Type 2017-2028 (USD Million)
  • TABLE Superdisintegrants Market: Formulation Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Formulation
  • TABLE Global Superdisintegrants Market, by Formulation 2017-2028 (USD Million)
  • TABLE Superdisintegrants Market: Therapeutic Area Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Superdisintegrants Market, by Therapeutic Area 2017-2028 (USD Million)
  • TABLE Superdisintegrants Market: Regional snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Superdisintegrants Market, by Region 2017-2028 (USD Million)
  • TABLE North America Superdisintegrants Market, by Country, 2017-2028 (USD Million)
  • TABLE North America Superdisintegrants Market, by Type, 2017-2028 (USD Million)
  • TABLE North America Superdisintegrants Market, by Formulation, 2017-2028 (USD Million)
  • TABLE North America Superdisintegrants Market, by Therapeutic Area, 2017-2028 (USD Million)
  • TABLE Europe Superdisintegrants Market, by Country, 2017-2028 (USD Million)
  • TABLE Europe Superdisintegrants Market, by Type, 2017-2028 (USD Million)
  • TABLE EuropeSuperdisintegrants Market, by Formulation, 2017-2028 (USD Million)
  • TABLE EuropeSuperdisintegrants Market, by Therapeutic Area, 2017-2028 (USD Million)
  • TABLE Asia Pacific Superdisintegrants Market, by Country, 2017-2028 (USD Million)
  • TABLE Asia Pacific Superdisintegrants Market, by Type, 2017-2028 (USD Million)
  • TABLE Asia Pacific Superdisintegrants Market, by Formulation, 2017-2028 (USD Million)
  • TABLE Asia Pacific Superdisintegrants Market, by Therapeutic Area, 2017-2028 (USD Million)
  • TABLE Latin America Superdisintegrants Market, by Country, 2017-2028 (USD Million)
  • TABLE Latin America Superdisintegrants Market, by Type, 2017-2028 (USD Million)
  • TABLE Latin America Superdisintegrants Market, by Formulation, 2017-2028 (USD Million)
  • TABLE Latin America Superdisintegrants Market, by Therapeutic Area, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Superdisintegrants Market, by Country, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Superdisintegrants Market, by Type, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Superdisintegrants Market, by Formulation, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Superdisintegrants Market, by Therapeutic Area, 2017-2028 (USD Million)
目次
Product Code: ANV952

REPORT HIGHLIGHT

The Superdisintegrants Market size was valued at USD 490.7 Million in 2021, expanding at a CAGR of 7.2% from 2022 to 2028.

Superdisintegrants are one of the various excipient types utilized in the pharmaceutical industry for tablet-based medication administration. To assist them to dissolve when submerged in a liquid, superdisintegrants are added to solid dosage forms like pills or tablets. The tablet's increased surface area from breaking into smaller pieces speeds up medication release.

Market Dynamics:

The development of unique superdisintegrant mixtures is a significant advancement in the pharmaceutical sector. With the help of these preparations, manufacturers now have access to a wide range of superdisintegrants, such as co-processed excipients, which are made up of several synthetic superdisintegrants, natural and synthetic superdisintegrants, or synthetic superdisintegrants combined with other pharmaceutical excipients. The active components' fast action, helps to improve the way medications work. Disintegrants are specifically developed for use in the direct compression method of tablet formulations, which eliminates several wet and dry granulation-related processing steps. One of the fastest-growing drug delivery methods using superdisintegrants for direct compression is oral disintegrating tablets (ODTs). A favorable regulatory environment in the developed regions is also progressively supporting growth in the acceptance of innovative excipients. The creation and application of novel excipients have been supported by the International Pharmaceutical Excipients Council (IPEC). To reduce the expense and uncertainty associated with the use of innovative excipients in pharmaceutical formulations, the council has established a novel excipient review approach as an independent process. Therefore, the emergence of new superdisintegrants in the pharmaceutical industry is expected to drive market growth during the forecast period.

However, despite the expanding usage of excipients in medicines, the market for superdisintegrants still has a difficult time meeting up to the high standards set by regulators, consumers, drug manufacturers, and-most importantly-patients. Superdisintegrant production variations have an impact on both the important quality characteristics and the efficacy of drugs. Superdisintegrant concentration fluctuations from supplier to supplier or batch to batch have an impact on the interaction between excipients and drugs, which in turn has an impact on drug efficacy and quality.

COVID-19 Analysis:

The ongoing COVID-19 pandemic had a big effect on the bioanalytical and pharmaceutical industries, especially in the areas of therapeutic research and backing for ongoing drug trials. The dynamics of the industry were somewhat influenced by the difficulties faced by various existing procedures in managing the reduction in manpower at sites and the increased workloads for other COVID-19-related support. However, shortly, the business might slowly come back into existence due to increasing awareness of the higher risk of coronavirus infection among neurological patients. It has been demonstrated that in some patients, an overreactive reaction to the virus raises the risk of dementia, stroke, vascular diseases, and encephalitis. Orally disintegrating tablets are frequently employed as a therapy option for patients with neurological problems like these, therefore drug production is projected to experience a considerable increase, which will ultimately lead to good growth for the industry as a whole.

Geography: Segment Analysis

With the largest revenue share in the superdisintegrants market in 2021, North America dominated the market. A few significant market drivers are the rise in demand for generic medications, improved innovation in the production of superdisintegrants, and manufacturing methods. Additionally, some of the most prominent players in the market for superdisintegrants are based in North America.

However, during the projected period, Asia Pacific is anticipated to develop at the fastest rate. Growth in the Asia Pacific region is anticipated to be fueled by aspects such as rising outsourcing of excipients, including superdisintegrants, production of new superdisintegrants, and adoption of novel technologies (New drug delivery system).

Recent Development:

In March 2021, Formulationbio announced the Launch of Disintegrant Excipients for Pharmaceutical Preparation.

Key features of the study:

This proposed research study on the Superdisintegrants market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Superdisintegrants market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Superdisintegrants market

The impact of COVID-19 on the Superdisintegrants market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Superdisintegrants market post-COVID will also be covered.

To give the users of this report a comprehensive view of the Superdisintegrants market, we have also included a competitive landscape and key innovator analysis for the Superdisintegrants market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Superdisintegrants market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global Superdisintegrants market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SUPERDISINTEGRANTS MARKET KEY PLAYERS

BASF SE

DuPont

Ashland Global Holdings Inc.

Roquette Freres

DFE Pharma

JRS PHARMA

Asahi Kasei Corporation

Merck KGaA

Corel Pharma Chem

Avantor Performance Materials

NIPPO SODA CO., LTD.

Sigachi Industries

Colorcon

NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.

GLOBAL SUPERDISINTEGRANTS MARKET, BY TYPE

Natural Superdisintegrants

Synthetic Superdisintegrants

Others

GLOBAL SUPERDISINTEGRANTS MARKET, BY FORMULATION

Tablets

Capsules

GLOBAL SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA

Gastrointestinal Diseases

Neurological Diseases

Oncology

Infectious Diseases

Cardiovascular Diseases

Hematological Diseases

Inflammatory Diseases

GLOBAL SUPERDISINTEGRANTS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. Superdisintegrants Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by Formulation
    • 2.1.3. Market Snippet by Therapeutic Area
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. Superdisintegrants Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Superdisintegrants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Superdisintegrants Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Superdisintegrants Market Landscape

  • 6.1. Market Share Analysis, 2021
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Superdisintegrants Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2021 & 2028 (%)
    • 7.1.2. Natural Superdisintegrants
    • 7.1.3. Synthetic Superdisintegrants
    • 7.1.4. Others

8. Superdisintegrants Market - By Formulation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Formulation, 2021 & 2028 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules

9. Superdisintegrants Market - By Therapeutic Area

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Area, 2021 & 2028 (%)
    • 9.1.2. Gastrointestinal Diseases
    • 9.1.3. Neurological Diseases
    • 9.1.4. Oncology
    • 9.1.5. Infectious Diseases
    • 9.1.6. Cardiovascular Diseases
    • 9.1.7. Hematological Diseases
    • 9.1.8. Inflammatory Diseases

10. Superdisintegrants Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Formulation, 2017 - 2028 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. BASF SE
    • 11.2.2. DuPont
    • 11.2.3. Ashland Global Holdings Inc.
    • 11.2.4. Roquette Freres
    • 11.2.5. DFE Pharma
    • 11.2.6. JRS PHARMA
    • 11.2.7. Asahi Kasei Corporation
    • 11.2.8. Merck KGaA
    • 11.2.9. Corel Pharma Chem
    • 11.2.10. Avantor Performance Materials
    • 11.2.11. NIPPO SODA CO., LTD.
    • 11.2.12. Sigachi Industries
    • 11.2.13. Colorcon
    • 11.2.14. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us